Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
MYL7	"MYL2A, MYLC2A"	ENSG00000106631	"Myosin light chain 7"	Q01449	7	44138864-44141332	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	822	"heart muscle: 639.9"	"Group enriched"	"Detected in some"	21	"BEWO: 15.0;CACO-2: 50.9"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA013331, CAB033884, HPA039262"	Enhanced									"CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418"	"unprognostic (1.00e-2)"	"unprognostic (7.99e-2)"		"unprognostic (4.36e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.51e-1)"				"unprognostic (1.28e-1)"	"unprognostic (7.85e-2)"				"unprognostic (1.67e-1)"		"unprognostic (7.28e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	639.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	50.9	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	418	"heart muscle: 1267.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.2;SH-SY5Y: 11.7"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"olfactory region: 28.1"	"Region enriched"	"Detected in some"	5	"olfactory region: 21.2"	HPA058269	Enhanced				"Secreted to blood"	190000	190000			"HPA058269: AB_2683660"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	1267.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.3	0.8	0.0	0.5	3.0	1.1	1.6	2.6	2.1	0.0	0.0	1.6	0.9	0.0	0.0	0.0	6.5	2.6	4.2	0.3	0.0	4.0	0.0	0.0	0.0	1.0	2.6	2.7	1.5	6.4	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	5.8	5.0	0.0	0.9	0.5	7.5	1.9	0.7	0.6	0.8	0.8	0.0	1.8	12.2	11.7	0.7	0.0	2.2	1.6	0.2	0.4	2.1	4.2	3.4	0.3	1.3	3.1	4.8	0.2	3.4	1.1	0.0	0.4	0.0	0.1	0.8	0.4	1.3	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.5	0.0	0.0	3.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	367	"heart muscle: 419.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 8.6;HMC-1: 14.4;K-562: 26.2;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 1.0"	"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol		1700000	1700000	Cytosol	Cytosol	"CAB009349: AB_793465, HPA046428: AB_2679661"	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	419.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.2	1.1	4.5	0.0	0.6	0.9	0.2	0.0	0.0	8.6	2.0	0.0	1.2	0.4	0.0	14.4	0.0	0.4	0.0	0.2	0.0	26.2	0.5	0.0	0.4	0.1	0.0	0.5	0.3	1.1	0.3	0.0	1.3	0.0	0.0	1.5	0.0	0.0	0.2	2.0	6.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858931	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"heart muscle: 348.6"	"Group enriched"	"Detected in some"	8	"BEWO: 33.4;CACO-2: 86.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"								"Secreted to blood"									"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	348.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.9	0.5	0.4	0.7	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.5	0.2	86.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.8	0.4	1.0	1.0	0.6	1.0	0.5	0.5	1.1	1.1	0.0	0.7	0.3	0.9	0.7	0.9	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377762	"Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	241	"heart muscle: 679.2"	"Cell line enriched"	"Detected in some"	26	"RH-30: 185.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"CAB015371, HPA015774, HPA017888"	Enhanced		Uncertain	"Nucleoplasm,Nucleoli,Focal adhesion sites"		50000	50000	"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	0.1	0.3	0.1	0.1	0.7	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	679.2	0.9	0.0	1.9	0.0	0.7	0.3	0.1	1.1	0.1	0.3	0.0	0.2	0.7	0.1	0.7	0.0	0.0	0.2	0.1	2.0	1.3	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.4	0.0	0.0	185.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	2.1	0.9	0.0	0.1	1.1	0.1	0.0
MYBPC3	"CMH4, FHC, MYBP-C"	ENSG00000134571	"Myosin binding protein C, cardiac"	Q14896	11	47331397-47352702	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	108	"heart muscle: 199.6"	"Cell line enriched"	"Detected in single"	17	"U-937: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Region enriched"	"Detected in single"	33	"cerebellum: 38.5"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced					44000	44000			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	199.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"heart muscle: 712.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 107.4"	"Group enriched"	"Detected in some"	7	"testis cancer: 2.4;thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.2"	"Group enriched"	"Detected in many"	6	"amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8"	"Low region specificity"	"Detected in all"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		140000	140000	"Plasma membrane"	"Plasma membrane"	"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	0.1	0.0	0.0	0.1	0.0	10.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	712.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.8	3.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.0	0.1	0.6	4.6	0.1	0.1	0.2	0.2	5.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	107.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	25.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
MYBPHL		ENSG00000221986	"Myosin binding protein H like"	A2RUH7	1	109292365-109307041	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"heart muscle: 64.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;Daudi: 1.5;Hep G2: 6.5;K-562: 1.7;RH-30: 3.8;THP-1: 1.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (6.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (5.89e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.10e-1)"	"unprognostic (7.05e-9)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.64e-1)"	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.3	1.3	0.0	64.6	0.4	0.1	0.0	0.0	0.7	0.0	1.4	0.1	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.8	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.1	0.6	0.4	0.1	1.4	0.1	0.4	0.9
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381990-23408277	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"heart muscle: 313.7"	"Cell line enriched"	"Detected in single"	23	"NTERA-2: 10.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced					20000000	20000000			"CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: , HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.1	313.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	8.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LRRC10	"HRLRRP, LRRC10A"	ENSG00000198812	"Leucine rich repeat containing 10"	Q5BKY1	12	69608564-69611162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"heart muscle: 42.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (3.76e-4)"										"unprognostic (4.59e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	1.0	0.5	0.4	0.8	0.1	0.1	0.5	0.6	0.6	0.0	0.0	0.5	0.1	0.0	0.9	0.4	0.3	0.3	1.0	0.3	0.1	0.7	0.0	0.1	0.0	2.4	0.7	0.5	0.7	0.6	0.1	0.0	0.8	0.2	0.6	0.6	0.0	0.4	0.6	0.1	0.1	0.0	0.8	0.4	0.2	0.4	0.9	0.1	0.1	0.8	1.2	0.8	0.9	0.0	0.1	0.0	0.3	0.1	0.3	0.2	0.8	0.4	0.4	0.6	0.3	0.8	1.0	1.3	0.1	0.4	0.5	0.4	0.6	0.2	0.5	0.7	0.5	0.6	0.1	1.3	0.8	0.7	1.0	0.4	0.3	1.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTC1	"ACTC, CMD1R"	ENSG00000159251	"Actin, alpha, cardiac muscle 1"	P68032	15	34788096-34796139	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"heart muscle: 243.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 36.4;LHCN-M2: 147.6;RH-30: 70.7"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 20.7;prostate cancer: 5.1;testis cancer: 6.9;urothelial cancer: 7.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB037330, HPA041264, HPA041271"	Enhanced					6200000000	6200000000			"CAB037330: , HPA041264: AB_2677383, HPA041271: "	"unprognostic (8.18e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavourable (3.72e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.26e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (5.68e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (9.32e-4)"	1.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0			0.0	0.1	0.0	0.2	0.0	0.0	243.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.9	0.0		0.6	12.5	8.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0			0.0		0.0	9.5	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	147.6	0.0	0.0	0.0	0.1	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4										
RD3L	"TDRD9-AS1, TDRD9AS1"	ENSG00000227729	"Retinal degeneration 3-like"	P0DJH9	14	103940426-103942308	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	16	"heart muscle: 32.6"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			HPA067971	Enhanced									"HPA067971: AB_2685935"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.1	0.2	0.0	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0
SBK3	SgK110	ENSG00000231274	"SH3 domain binding kinase family member 3"	P0C264	19	55540656-55545543	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 24.2"	"Cell line enhanced"	"Detected in some"		"A549: 9.2;CACO-2: 3.2;CAPAN-2: 5.4;NTERA-2: 2.5;RH-30: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA078322			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA078322: AB_2732379"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.47e-5)"	"unprognostic (4.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-1)"	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0			0.2	0.0	0.0	1.7	0.0	0.1	24.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.3	3.2	5.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	2.5	0.6	0.2	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	1.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Group enriched"	"Detected in some"	4	"LHCN-M2: 21.5;RH-30: 17.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.3	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.8	2.7	0.0	0.3	0.0	1.1	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	3.5	0.0	0.0	21.5	1.0	0.0	0.0	2.0	0.0	0.0	17.9	0.0	0.0	2.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0
BMP10		ENSG00000163217	"Bone morphogenetic protein 10"	O95393	2	68865481-68871517	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"heart muscle: 110.1"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	120000	120000																		"unprognostic (1.74e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.1	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NKX2-5	"CSX, CSX1, NKX2.5, NKX2E, NKX4-1"	ENSG00000183072	"NK2 homeobox 5"	P52952	5	173232109-173235357	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 95.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 20.5;NTERA-2: 7.4;SK-MEL-30: 9.1;U-2 OS: 16.9;U-251 MG: 12.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065034			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA065034: AB_2685409"	"unprognostic (3.81e-1)"	"unprognostic (8.53e-2)"		"unprognostic (2.62e-2)"	"unprognostic (9.57e-3)"	"unprognostic (3.22e-3)"		"unprognostic (6.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.31e-1)"			"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"		"unprognostic (1.77e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	95.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.2	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.0	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	20.5	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.3	4.2	0.0	9.1	0.0	0.0	0.0	3.9	16.9	5.2	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319578-51809445	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"heart muscle: 59.1"	"Group enriched"	"Detected in some"	7	"AF22: 10.8;Daudi: 8.1;SH-SY5Y: 8.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA007919: "	"prognostic unfavourable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.1	0.1	0.3	0.1	0.2	0.0	0.2	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.3	7.9	0.4	0.1	0.7	59.1	0.2	0.3	1.0	0.1	0.2	0.3	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.0	1.8	1.1	0.3	0.9	0.2	0.2	0.1	0.2	0.3	0.1	5.2	0.0	0.1	0.2	2.5	0.3	0.2	0.1	1.5	0.3	0.3	0.0	0.0	0.1	0.0	0.6	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.9	0.2	0.3	0.3	0.3	0.3	0.0
TECRL	"DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL"	ENSG00000205678	"Trans-2,3-enoyl-CoA reductase like"	Q5HYJ1	4	64275257-64409468	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 131.5"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																															0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	131.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.1	0.0	0.0	0.2	0.2	1.3	0.0	0.0	0.3	0.0	0.9	1.0	0.7	1.2	0.6	0.2	0.3	1.2	0.0	0.2	0.2	1.2	0.8	0.6	0.3	0.3	0.6	0.3	0.1	0.4	0.6	0.0	0.8	1.5	1.5	0.2	1.3	0.7	0.1	0.5	0.2	0.3	0.2	0.8	1.2	0.2	0.2	0.5	0.9	0.7	0.2	0.6	0.9	0.5	2.7	0.6	0.2	0.7	0.5	0.1	0.1	0.4	0.5	0.7	1.2	0.9	0.8	0.8	1.1	0.3	0.8	0.5	0.9	0.6	0.6	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0
TNNI3K	CARK	ENSG00000116783	"TNNI3 interacting kinase"	Q59H18	1	74235401-74544428	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"heart muscle: 44.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;HSkMC: 2.7;RPTEC TERT1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.3;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.3;T-cells: 1.0"																				"unprognostic (1.04e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.66e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.77e-2)"	0.7	0.6	1.1	0.5	1.5	0.0	1.0	6.0	1.7	0.5	0.5	0.5	0.5	0.2	0.5	1.7	0.5	0.7	0.5	44.6	1.1	1.3	2.2	0.5	0.5	0.5	0.6	0.5	0.7	0.5	0.3	0.6	0.5	0.9	0.5	0.3	0.5	0.5	1.2	0.5	0.9	0.5	0.6	0.5	0.5	0.1	1.8	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.3	1.9	0.0	2.3	0.0	1.0	0.1	0.0	0.6	0.7	0.0	0.5	1.6	0.0	0.0	1.3	0.3	1.0	0.0	3.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.5	2.7	1.6	0.2	0.0	0.5	0.0	0.8	1.1	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	2.6	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	2.3	0.0	0.1	0.3	1.0	0.1	0.3	0.2	0.4	0.0	0.0	0.2	1.9	0.0	0.1	1.1	1.5	6.0	1.7	1.1	1.3	0.6	0.5	0.9	0.5
POPDC2	POP2	ENSG00000121577	"Popeye domain containing 2"	Q9HBU9	3	119636457-119665324	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 90.5"	"Cell line enriched"	"Detected in single"	27	"SH-SY5Y: 25.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024255	Enhanced									"HPA024255: AB_1855545"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.91e-3)"	"unprognostic (9.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-2)"	1.3	0.3	0.2	1.0	0.2	0.0	0.6	0.3	0.2	1.8	16.0	0.2	7.6	0.6	2.0	1.3	3.3	1.8	6.1	90.5	0.2	0.0	0.5	0.3	0.3	1.4	0.2	0.3	0.8	0.7	0.1	0.2	0.3	0.3	5.0	1.5	0.3	0.6	13.4	12.1	0.4	2.2	12.6	0.2	0.5	2.4	0.5	0.2	0.3	0.5	3.8	0.8	10.2	1.1	0.9	0.7	2.1	3.0	0.3	2.2	0.4	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	25.5	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.7	0.0	0.1	0.1	0.2	0.5	2.1	0.1	1.3	0.9	0.1	1.1	0.3	1.1	1.0	0.1	0.9	2.2	0.7	0.1	0.3	3.0	0.7	1.6	0.4	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	0.3	0.2
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.3	0.5	0.0	0.0	7.7	10.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	2.7	3.9	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0
C15orf41	"FLJ22851, HH114, MGC11326"	ENSG00000186073	"Chromosome 15 open reading frame 41"	Q9Y2V0	15	36579611-36810248	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 79.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061023	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA061023: AB_2684417"	"unprognostic (1.82e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-6)"	"unprognostic (1.22e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.58e-1)"	2.3	4.1	3.4	4.1	8.9	0.8	2.4	4.2	4.1	5.5	4.0	2.8	3.5	4.9	8.8	2.7	7.0	3.3	4.7	79.9	2.5	2.4	2.3	2.8	2.9	1.9	3.1	2.3	3.6	1.9	2.7	3.5	1.8	2.8	5.4	2.7	2.7	3.5	5.3	7.9	4.2	3.0	16.0	3.4	2.0	2.8	4.9	3.7	2.8	2.2	7.2	3.9	7.7	6.2	3.6	2.4	0.4	2.1	4.9	7.8	2.0	12.8	7.0	8.8	3.3	9.7	11.8	3.6	6.3	3.1	7.9	6.5	9.6	5.2	2.0	6.4	15.2	23.8	9.1	5.3	9.1	1.0	6.3	6.8	6.4	7.0	8.8	5.9	5.0	8.8	5.9	6.7	3.7	7.5	8.6	2.2	10.8	5.9	1.7	3.3	4.8	3.6	5.4	2.5	1.4	5.1	17.8	5.1	3.2	4.2	4.2	3.3	3.9	9.0	5.3	7.8	4.3	5.2	1.7	5.3	7.2	9.5	9.9	10.3	7.2	0.0	0.8	0.4	4.3	2.1	3.9	3.6	3.4	4.2	2.4	3.5	4.1	3.5	0.1	4.9	0.8	1.8	7.8	2.0	3.4	8.9	4.2	4.1	2.5	2.4	3.1	2.3	2.8	3.7
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480170	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 180.3"	"Cell line enhanced"	"Detected in many"		"A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 24.0;T-reg: 29.2"	"Group enriched"	"Detected in many"	19	"B-cells: 17.9;T-cells: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		490000	490000	Nucleoli	Nucleoli	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	22.8	11.5	27.5	9.1	24.6	1.6	16.9	3.6	30.3	20.2	10.1	9.4	33.7	7.9	15.3	30.6	25.6	29.5	24.5	180.3	22.6	18.7	20.0	6.9	28.5	9.3	13.5	16.9	12.5	12.6	4.3	20.4	29.1	10.4	14.6	3.8	8.8	18.4	28.0	10.7	28.4	9.1	24.9	10.3	13.0	11.3	10.9	7.8	1.0	17.8	23.8	13.3	23.8	17.5	17.9	0.9	0.2	0.5	1.2	29.2	3.4	0.4	37.7	5.5	15.0	0.9	3.9	1.6	1.7	0.4	0.5	0.1	1.1	7.0	0.0	38.6	12.3	21.6	0.7	9.2	0.0	0.2	0.2	0.0	23.7	14.3	4.0	0.0	3.2	1.9	0.8	0.9	5.1	36.1	0.0	0.3	5.4	55.4	0.1	0.1	1.5	22.7	0.0	0.7	1.6	25.4	0.1	8.4	20.9	2.4	43.4	0.3	37.2	0.0	14.0	12.5	5.9	0.3	7.0	0.1	0.1	0.1	3.6	0.0	25.2	0.0	0.5	0.0	2.4	0.2	2.3	14.4	24.0	5.3	0.9	17.9	5.9	1.6	0.2	1.2	0.1	0.1	29.2	3.4	27.5	24.6	3.6	30.3	22.6	18.7	13.5	16.9	10.4	7.8
LBHD1	"C11orf48, MGC2477"	ENSG00000162194	"LBH domain containing 1"	Q9BQE6	11	62662817-62672255	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 67.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA012127, HPA023592"	Uncertain									"HPA012127: AB_1845527, HPA023592: AB_1845528"	"unprognostic (4.34e-4)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.18e-8)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.78e-8)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.72e-3)"	4.7	14.7	1.7	6.2	3.9	6.9	4.2	3.4	3.6	3.8	4.0	3.9	7.6	4.0	2.3	5.4	4.0	4.1	5.3	67.7	3.4	2.1	4.1	8.3	4.4	8.3	1.8	3.3	3.3	4.1	7.5	4.4	2.3	3.7	4.6	4.1	4.5	4.2	10.0	4.8	2.6	6.0	2.5	3.1	10.4	4.6	6.7	2.3	6.2	4.6	3.0	6.5	4.8	2.6	4.9	7.1	5.7	6.2	8.0	7.0	4.3	2.0	3.5	2.2	1.7	3.4	6.4	4.9	2.8	4.1	4.6	3.7	2.8	23.7	7.1	6.1	3.4	9.2	2.3	6.4	3.6	9.5	7.3	5.9	9.7	2.0	5.0	5.5	7.8	8.7	0.7	8.1	2.6	2.5	6.1	6.5	2.9	3.5	3.4	8.3	2.7	3.1	8.4	5.4	13.0	6.0	4.0	2.4	3.6	3.1	4.3	8.8	7.8	8.3	1.9	2.9	1.8	2.9	2.9	10.7	9.2	6.7	2.6	5.7	2.9	2.2	6.2	5.7	6.6	4.5	5.7	4.6	3.7	7.0	5.4	4.9	5.1	4.1	1.8	8.0	3.4	7.1	2.2	4.3	1.7	3.9	3.4	3.6	3.4	2.1	1.8	3.3	3.7	2.3
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 60.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	16.9	3.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.7	15.3	0.0	10.4	0.0	15.1	2.1	13.4	0.0	0.0	4.8	0.1	0.7	15.9	9.5	0.9	0.2	0.0	12.7	0.0	14.7	0.5	3.0	4.8	1.4	4.4	0.0	0.1	9.3	2.9	0.0	7.4	5.0	4.5	8.0	1.9	1.6	0.7	3.5	0.0	7.7	0.2	0.1	0.0	6.8	0.0	4.1	4.0	0.0	0.1	0.0	0.0	0.8	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548298-118560730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 337.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.4;Karpas-707: 1.6;NB-4: 1.9;U-2197: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005597, HPA026900"	Enhanced									"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (5.59e-4)"	9.0	1.8	0.4	2.7	0.5	0.0	5.4	0.4	0.6	22.3	22.2	0.0	9.8	2.0	21.1	22.3	27.3	11.6	29.8	337.5	0.4	0.5	6.4	0.4	5.3	0.8	0.7	1.4	18.6	0.5	0.1	0.4	0.1	1.4	14.4	3.9	0.0	1.6	6.0	68.4	1.5	14.0	30.8	1.2	0.6	6.5	12.3	0.0	0.0	2.8	23.7	0.8	32.2	6.6	0.3	0.0	1.3	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.3	0.5	0.2	0.0	0.2	1.6	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.1	1.0	0.0	0.7	0.2	0.8	0.4	0.1	0.0	0.4	0.0	0.5	0.3	0.2	1.3	0.3	0.2	0.3	0.5	0.0	1.1	0.1	0.0	0.4	1.3	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.3	1.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.6	0.4	0.5	0.7	1.4	1.4	0.0
FGF18	"FGF-18, ZFGF5"	ENSG00000156427	"Fibroblast growth factor 18"	O76093	5	171419656-171457623	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 23.0"	"Cell line enriched"	"Detected in some"	57	"EFO-21: 65.1"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.0;ovarian cancer: 21.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018795	Uncertain				"Secreted in other tissues"					"HPA018795: "	"unprognostic (3.01e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-8)"	"unprognostic (7.33e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.76e-2)"	4.4	0.6	0.6	2.8	0.6	0.1	2.0	0.4	1.2	1.3	0.8	0.5	0.0	1.1	1.6	1.5	0.9	2.0	1.4	23.0	0.5	0.4	1.3	0.4	2.9	0.5	0.4	0.0	1.6	0.9	0.1	1.8	0.9	1.6	2.2	0.3	0.3	1.0	0.7	5.4	1.8	2.2	1.2	0.9	1.1	0.7	1.0	0.3	0.2	2.2	2.5	0.8	2.2	0.5	0.9	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	65.1	0.0	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.6	0.4	1.2	0.5	0.4	0.4	0.0	1.6	0.3
FITM2	"C20orf142, dJ881L22.2, FIT2"	ENSG00000197296	"Fat storage inducing transmembrane protein 2"	Q8N6M3	20	44302838-44311169	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 56.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.92e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (8.98e-12)"	"unprognostic (2.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.49e-3)"	8.8	9.9	5.0	2.6	5.7	1.2	9.5	7.1	8.2	4.0	4.5	4.3	3.8	3.8	3.7	7.7	3.1	3.5	3.3	56.7	4.9	5.1	7.7	8.0	3.6	2.0	4.7	5.5	4.3	7.8	13.0	4.5	1.9	6.6	5.8	5.3	4.7	5.3	4.2	6.9	4.5	3.7	4.6	4.7	2.5	3.8	3.6	5.1	0.2	5.5	4.4	2.4	3.9	3.8	2.0	2.7	1.7	3.0	3.8	6.2	2.5	4.4	6.9	2.9	4.2	20.9	8.6	3.0	7.3	5.3	5.8	3.2	8.5	3.2	3.1	4.3	8.2	10.1	3.7	4.9	6.3	0.9	1.7	0.9	4.3	14.2	4.4	1.9	2.6	6.5	11.2	4.0	3.1	4.1	1.7	9.1	5.8	13.9	0.7	2.1	0.7	8.9	1.2	5.5	3.0	3.3	4.2	1.8	2.1	15.5	8.7	6.5	10.7	1.5	5.0	18.6	8.3	10.7	4.3	3.4	8.7	0.8	8.2	3.1	9.2	1.4	3.0	1.7	3.4	2.7	3.5	1.8	3.6	2.8	2.7	2.0	6.2	4.8	1.4	3.8	2.1	1.7	3.2	2.5	5.0	5.7	7.1	8.2	4.9	5.1	4.7	5.5	6.6	5.1
NEBL	"LASP2, LNEBL"	ENSG00000078114	Nebulette	O76041	10	20779973-21174187	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 123.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 13.6;SCLC-21H: 27.5;SH-SY5Y: 16.6;SK-BR-3: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA013994, HPA013995"	Approved									"HPA013994: AB_1854359, HPA013995: AB_1854360"	"unprognostic (3.79e-2)"	"unprognostic (1.92e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.20e-3)"	"unprognostic (2.36e-2)"	"unprognostic (8.42e-2)"	"prognostic favourable (2.77e-8)"	"unprognostic (3.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (5.56e-4)"	1.3	6.9	16.4	1.0	17.2	0.7	13.2	21.1	16.1	2.6	2.9	9.8	0.1	1.0	1.3	1.0	10.8	1.1	1.7	123.6	16.5	12.7	12.0	1.7	14.1	0.9	12.7	13.3	1.5	6.0	6.6	16.0	5.1	12.6	7.3	4.0	2.2	18.8	8.1	0.8	16.2	1.3	1.4	10.6	0.8	4.0	2.8	12.5	0.5	30.8	3.9	3.8	2.1	4.4	0.0	0.0	1.4	0.8	0.0	0.5	0.2	0.6	5.1	7.8	0.3	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.6	0.7	1.5	8.0	0.0	4.7	0.5	0.0	0.0	0.0	3.3	0.0	2.5	0.0	12.3	0.0	0.0	13.6	12.7	0.0	1.3	0.3	0.3	2.1	0.0	12.0	0.1	0.0	5.7	3.1	0.0	0.1	0.0	1.9	1.1	27.5	16.6	1.4	26.0	0.0	8.8	0.0	10.8	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.0	0.5	0.2	16.4	17.2	21.1	14.1	16.5	12.7	12.7	13.3	12.6	12.5
